Your browser doesn't support javascript.
loading
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy.
Santoni, Matteo; Buti, Sebastiano; Conti, Alessandro; Porta, Camillo; Procopio, Giuseppe; Sternberg, Cora N; Bracarda, Sergio; Basso, Umberto; De Giorgi, Ugo; Rizzo, Mimma; Derosa, Lisa; Ortega, Cinzia; Massari, Francesco; Milella, Michele; Bersanelli, Melissa; Cerbone, Linda; Muzzonigro, Giovanni; Burattini, Luciano; Montironi, Rodolfo; Santini, Daniele; Cascinu, Stefano.
Afiliación
  • Santoni M; Medical Oncology, AOU Ospedali Riuniti, Polytechnic University of the Marche Region, Via Conca 71, 60126, Ancona, Italy. mattymo@alice.it.
  • Buti S; Oncology Unit, University Hospital of Parma, Viale Antonio Gramsci 14, 43126, Parma, Italy. sebabuti@libero.it.
  • Conti A; Dipartimento di Scienze Cliniche Specialistiche ed Odontostomatologiche, Clinica di Urologia, AOU "Ospedali Riuniti", Università Politecnica delle Marche, Via Conca 71, 60126, Ancona, Italy. alessandro83conti@gmail.com.
  • Porta C; Medical Oncology, IRCCS San Matteo University Hospital Foundation, Piazzale C Golgi 19, 27100, Pavia, Italy. camillo.porta@gmail.com.
  • Procopio G; Department of Medical Oncology, Fondazione IRCCS, Istituto Nazionale dei Tumori, Via G. Venezian, Milan 1, 20133, Italy. Giuseppe.Procopio@istitutotumori.mi.it.
  • Sternberg CN; Department of Medical Oncology, San Camillo and Forlanini Hospitals, Circonvallazione Gianicolense XX, Rome, 00152, Italy. cora.sternberg@pansadoro.it.
  • Bracarda S; Department of Oncology, Ospedale San Donato USL-8, Istituto Toscano Tumori (ITT), Via Pietro Nenni, 20, 52100, Arezzo, Italy. sergio.bracarda@usl8.toscana.it.
  • Basso U; Medical Oncology 1, Istituto Oncologico Veneto, IRCCS, Via Gattamelata, 64, 35128, Padova, Italy. umberto.basso@ioveneto.it.
  • De Giorgi U; IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-I.R.S.T., Via Piero Maroncelli 40, 47014, Meldola, FC, Italy. ugo.degiorgi@irst.emr.it.
  • Rizzo M; Department of Medical Oncology, Cardarelli Hospital, via Cardarelli 9, 80131, Naples, Italy. rizzo.mimma@gmail.com.
  • Derosa L; UO Oncologia Medica 2 Azienda Ospedaliero, Universitaria Pisana Istituto Toscano Tumori, Via Roma 67, 56100, Pisa, Italy. deros.lisa@gmail.com.
  • Ortega C; Oncology Foundation of Piedmont, Institute for Cancer Research and Treatment, Laboratory Medicine, Via Orbassano 6, 10060, Candiolo, Italy. cinzia.ortega@gmail.com.
  • Massari F; Medical Oncology, 'G.B. Rossi' Academic Hospital, University of Verona, Piazzale Scuro 10, 37134, Verona, Italy. fmassari79@gmail.com.
  • Milella M; Medical Oncology A, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144, Rome, Italy. milella@ifo.it.
  • Bersanelli M; Oncology Unit, University Hospital of Parma, Viale Antonio Gramsci 14, 43126, Parma, Italy.
  • Cerbone L; Department of Medical Oncology, San Camillo and Forlanini Hospitals, Circonvallazione Gianicolense XX, Rome, 00152, Italy. cerbone.linda@gmail.com.
  • Muzzonigro G; Dipartimento di Scienze Cliniche Specialistiche ed Odontostomatologiche, Clinica di Urologia, AOU "Ospedali Riuniti", Università Politecnica delle Marche, Via Conca 71, 60126, Ancona, Italy. g.muzzonigro@univpm.it.
  • Burattini L; Medical Oncology, AOU Ospedali Riuniti, Polytechnic University of the Marche Region, Via Conca 71, 60126, Ancona, Italy. l.burattini@ospedaliriuniti.marche.it.
  • Montironi R; Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, AOU Ospedali Riuniti, via Conca 71, 60126, Ancona, Italy. r.montironi@univpm.it.
  • Santini D; Oncologia Medica, University Campus Bio-Medico Roma, Via Álvaro del Portillo 200, 00128, Rome, Italy. d.santini@unicampus.it.
  • Cascinu S; Medical Oncology, AOU Ospedali Riuniti, Polytechnic University of the Marche Region, Via Conca 71, 60126, Ancona, Italy. s.cascinu@univpm.it.
Target Oncol ; 10(4): 517-22, 2015 Dec.
Article en En | MEDLINE | ID: mdl-25559290

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma de Células Renales / Inhibidores de Proteínas Quinasas / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Target Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma de Células Renales / Inhibidores de Proteínas Quinasas / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Target Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Italia